Persistent acid secretion during omeprazole therapy: A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy

American Journal of Gastroenterology

Volumn 91, Issue 8, 1996, Pages 1527-1531

  Leite, Louis P ^a   Johnston, Brian T ^a   Just, Robert J ^a   Castell, Donald O ^a  

^a GRADUATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH PH; TREATMENT FAILURE;

ANTI-ULCER AGENTS; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MONITORING, AMBULATORY; OMEPRAZOLE; RANDOM ALLOCATION; TIME FACTORS; TREATMENT FAILURE;

EID: 0029781528     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Nebel OT, Forbes MF, Castell DO. Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Am J Dig Dis 1976;21: 953-6
2. DeVault KR, Castell DO. Current diagnosis and treatment of gastroesophageal reflux disease. Mayo Clin Proc 1994;69:867-6
3. Klinkenberg-Knol EC, Meuwissen, SG. Medical therapy of patients poorly responsive to H2-receptor antagonist therapy. Digestion 1992; 51(Suppl 1):44-8
4. Just R, Gideon RM, Castell D. Omeprazole resistance in patients with gastroesophageal reflux. Gastroenterology 1994;106:A101 (abstract)
5. Klinkenberg-Knol EC, Meuwissen SG. Combined gastric and esophageal 24 hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990;4(5):485-95
6. Klinkenberg-Knol EC, Festen HP, Jansen JB, et al. Long term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety. Ann Intern Med 1994;121(3):161-7
7. 2 antagonist and omeprazole non-responders. Ital J Gastroenterol. 1991;23(8):551-2
8. Savarino V, Mela GS, Zentilin P, et al. Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? Gastroenterology 1990;99:1542-3
9. Kuo B, Castell DO. Omeprazole 20 mg bid provides better acid suppression than a single dose of 40 mg. Gastroenterology 1994;106 4(2):A1034 (abstract)
10. Mihaly GW, Prichard PJ, Smallwood RA, et al. Simultaneous high pressure liquid chromatographic analysis of omeprazole and its sulphone and sulfide metabolites in human plasma and urine. J Chromatogr 1983;278:311-9
11. Andersson T, Cederberg C, Heggelund A, et al. The pharmacokinetics of single and repeated once-daily doses of 10, 20, and 40 mg omeprazole as enteric coated granules. Drug Invest 1991;3(1):45-52
12. Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. New York: Marcel Dekker, 1982.
13. Howden CW. Clinical pharmacology of omeprazole. Clin Pharmacokinet 1991;20:38-49
14. Holt S, Howden CW, Omeprazole: Overview and opinion. Dig Dis Sci 1991;36:385-94
15. Sachs G, Shin M, Besancon M, et al. The continuing development of gastric acid pump inhibitors. Aliment Pharmacol Ther 1993;7(Suppl 1): 4-12
16. Maton PN. Omeprazole. N Engl J Med. 1991;324(14):965-75
17. Dent J, Downton J, Heddle R, et al. Effects of omeprazole on peptic esophagitis and esophageal motility and pH. Scand J Gastroenterol 1986;118:181 (abstract)
18. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95:903-12
19. Sandmark S, Carlsson R, Fause O, et al. Omeprazole or ranitidine in the treatment of reflux esophagitis: Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988;23: 625-32
20. Havelund T, Laursen LS, Skoubo-Kristensen E, et al. Omeprazole and ranitidine in the treatment of reflux esophagitis: Double blind comparative trial. Br Med J 1988;296:89-92
21. Brunner G, Creutzfelt W. Omeprazole in the long term management of patients with acid-related diseases resistant to ranitidine. Scand J Gastroenterol 1989;166:101-5
22. Klinkenberg-Knol EC, Jansen ABM, Festoon HM, et al. Double blind multicenter comparison of omeprazole and ranitidine in the treatment of reflux esophagitis. Lancet 1987;1:349-51
23. Wetzel DJ, Bonine M. Long term management of hemorrhagic esophagitis with cimetidine and omeprazole. Aust N Z J Med 1986;16: 226-8
24. Fausa O, Aaland E, Lotveit T. Omeprazole in the treatment of patients with erosive esophagitis resistant to treatment with H2 receptor antagonists. Scand J Gastroenterol 1987;135:38 (abstract)
25. Hameeteman W, Tytgat GN. Healing of chronic Barrett's ulcers with omeprazole. Am J Gastroenterol 1986;81:764-6
26. Bardhan KD, Morris P, Thompson M, et al. Value of omeprazole in the management of erosive esophagitis refractory to high dose cimetidine. Gut 1987;28:A1375 (abstract)
27. Walt RP, Gomes M de FA, Wood EC, et al. Effect of daily omeprazole on 24 hour intragastric acidity. Br Med J 1983;287:12-4
28. Müller P, Dammann H-G, Seitz H, et al. Effect of repeated once daily oral omeprazole on gastric secretion. Lancet 1983;i:66
29. Prichard PJ, Yeomans ND, Mihaly GW, et al. Omeprazole: A study of its inhibition of gastric pH and oral pharmacokinetics after morning and evening dosage. Gastroenterology 1985;88:64-9
30. Lazon-Miller S, Pounder RE, Hamilton MR, et al. Twenty-four intragastric acidity and plasma gastric concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1987;1:239-51
31. Hatlebakk JG, Berstad A, Carling L, et al. Lansoprazole versus omeprazole in short term treatment of reflux esophagitis: Results of a Scandinavian multicenter trial. Gastroenterology 1992;102:A80 (abstract)
32. Laursen LS, Bondesen S, Hansen J, et al. Omeprazole 20 mg or 40 mg for the treatment of gastroesophageal reflux disease? A double blind comparative study. Gastroenterology 1992;102:A110 (abstract)
33. Savarino V, Sandro Mela G, Zentilin P. Variability in interindividual response to various doses of omeprazole. Dig Dis Sci 1994;39:161-8
34. Bracy N, Gideon RM, Castell DO. Control of intragastric pH with omeprazole in patients with gastroesophageal reflux. Gastroenterology 1995;108:A62 (abstract)
35. Gupta PK, Flockhart N, Soukhova N, et al. Omeprazole metabolism in patients with refractory gastroesophageal reflux (GER). Gastroenterology 1994;106:A84 (abstract)
36. Katzka DA, Castell DO. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994;89:989-91